Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | -2.99% | -1.52% | -7.14% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.2M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | -18M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.63
x | P/E ratio 2025 * |
-1.26
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.17% |
Latest transcript on Artelo Biosciences, Inc.
1 day | -2.99% | ||
1 week | -1.52% | ||
Current month | -5.49% | ||
1 month | -14.75% | ||
3 months | -12.16% | ||
6 months | +2.36% | ||
Current year | -7.14% |
Managers | Title | Age | Since |
---|---|---|---|
Gregory Gorgas
CEO | Chief Executive Officer | 61 | 17-04-02 |
Andy Yates
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | 18-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 17-05-01 |
Steven Kelly
BRD | Director/Board Member | 59 | 17-05-01 |
Gregory Reyes
BRD | Director/Board Member | 70 | 20-11-29 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1.3 | -2.99% | 30,662 |
24-05-10 | 1.34 | -3.60% | 31,159 |
24-05-09 | 1.39 | +4.82% | 2,638 |
24-05-08 | 1.326 | +2.80% | 8,369 |
24-05-07 | 1.29 | -2.27% | 6,741 |
Delayed Quote Nasdaq, May 13, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.14% | 4.2M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.68% | 21.93B | |
-12.15% | 22.34B | |
-5.61% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- ARTL Stock